• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 8-K filed by PetVivo Holdings Inc.

    4/8/25 3:35:35 PM ET
    $PETV
    Medical/Dental Instruments
    Health Care
    Get the next $PETV alert in real time by email
    false 0001512922 0001512922 2025-04-07 2025-04-07 0001512922 us-gaap:CommonStockMember 2025-04-07 2025-04-07 0001512922 PETV:WarrantsMember 2025-04-07 2025-04-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    April 7, 2025

    Date of Report (Date of earliest event reported)

     

    PETVIVO HOLDINGS, INC.

    (Exact name of registrant as specified in its charter)

     

    Nevada   001-40715   99-0363559

    (State or other jurisdiction

    of incorporation)

     

    (Commission

    File Number)

     

    (IRS Employer

    Identification No.)

     

    5151 Edina Industrial Blvd.

    Suite 575

    Edina, Minnesota

      55439
    (Address of principal executive offices)   (Zip Code)

     

    (952) 405-6216

    Registrant’s telephone number, including area code

     

    Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered*
    Common Stock   PETV   OTCQB
    Warrants   PETVW   OTCPINK

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 4.01.Changes in Registrant’s Certifying Accountant.

     

    Resignation of Independent Registered Public Accounting Firm

     

    On April 1, 2025, in conjunction with its exit from providing audit services to publicly traded companies, Assurance Dimensions, LLC, also doing business as McNamara and Associates, LLC (“Assurance Dimensions”) resigned from its role as independent registered public accounting firm for PetVivo Holdings, Inc. (the “Company”).

     

    Assurance Dimensions’ reports on the Company’s consolidated financial statements as of and for the fiscal years ended March 31, 2024 and March 31, 2023 did not contain an adverse opinion or disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope or accounting principles.

     

    During the fiscal years ended March 31, 2024 and March 31, 2023 and the subsequent interim period through December 31, 2024, (i) there were no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K, between the Company and Assurance Dimensions on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, any of which that, if not resolved to Assurance Dimensions’ satisfaction, would have caused Assurance Dimensions to make reference to the subject matter of any such disagreement in connection with its reports for such years and interim period, and (ii) there were no reportable events within the meaning of Item 304(a)(1)(v) of Regulation S-K.

     

    The Company provided Assurance Dimensions with a copy of the above disclosures and requested that Assurance Dimensions furnish a letter addressed to the Audit Committee of the Company stating whether it agrees with the statements made herein. A copy of Assurance Dimensions’ letter dated April 1, 2025 is filed as Exhibit 16.1 to this Current Report on Form 8-K.

     

    Newly Engaged Independent Registered Public Accounting Firm

     

    On April 7, 2025, the Company engaged Stephano Slack LLC (“Stephano Slack”) as the Company’s new independent registered public accounting firm for the fiscal year ending March 31, 2025.

     

    During the Company’s fiscal years ended March 31, 2024 and March 31, 2023 and the subsequent interim period through December 31, 2024, neither the Company nor anyone on its behalf has consulted with Stephano Slack regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company’s financial statements, and neither a written report nor oral advice was provided to the Company that Stephano Slack concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing, or financial reporting issue, (ii) any matter that was the subject of a disagreement within the meaning of Item 304(a)(1)(iv) of Regulation S-K, or (iii) any reportable event within the meaning of Item 304(a)(1)(v) of Regulation S-K.

     

    Item 9.01 Financial Statements and Exhibits.

     

    (d) Exhibits – The following exhibits are filed as part of this report:

     

    16.1 Letter from Assurance Dimensions, LLC addressed to the Audit Committee of the Company dated April 1, 2025
       
    104 Cover Page Interactive Data File (formatted as Inline XBRL)

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized

     

      PETVIVO HOLDINGS, INC.
         
    Date: April 7, 2025 By: /s/ John Lai
      Name: John Lai
      Title: Chief Executive Officer

     

     

     

    Get the next $PETV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $PETV

    DatePrice TargetRatingAnalyst
    10/12/2021$7.00Buy
    ThinkEquity
    More analyst ratings

    $PETV
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • PETVIVO HOLDING, INC. ANNOUNCES DISTRIBUTION AGREEMENT WITH EQ ESPECIALIDADES

      MINNEAPOLIS, April 16, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative medical devices and other therapeutics for equine and companion animals, announced today it has entered into a definitive distribution agreement with Eq Especialidades ("Eq Especialidades"). Eq Especialidades will inventory, market and promote PetVivo's veterinary medical device, Spryng™ with OsteoCushion™ technology, throughout Mexico. Eq Especialidades sales and marketing activities will commence on April 1, 2025. SPRYNG® with OsteoCushion® Technology, is an intra-articular injectable veterinary m

      4/16/25 9:30:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. ANNOUNCES CLOSE OF SERIES B CONVERTIBLE PREFERRED STOCK OFFERING

      MINNEAPOLIS, March 31, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) and its wholly-owned subsidiary PetVivo Animal Health, Inc. (collectively "PetVivo" or the "Company") an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for horses, dogs and other companion animals announced today that the Company has recently entered into a Subscription Agreement to receive Five Million Dollars ($5,000,000) of equity financing in exchange for Five Million shares of Series B Convertible Preferred Stock ("Shares") (the "Offering"). The Company initially received Six Hundred Thousand Dollars ($600,000) of the Offering proceeds

      3/31/25 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Petvivo Holdings, Inc. and Digital Landia Corp. Announce Groundbreaking Strategic Alliance Agreement to Pioneer Agentic AI for Animal Communication

      MINNEAPOLIS, March 03, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW) (the "Company" or "PetVivo") an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for animals and Digital Landia Corp. a pioneer in Agentic AI solutions, today announced a transformative strategic alliance agreement. The collaboration centers on Pet AI, Digital Landia's revolutionary open-source platform that deciphers animal behavior through real-time analysis of vocalizations, body language, and physiological signals captured via smartphone cameras. This technology, which achieves 97% accuracy in translating animal communication,

      3/3/25 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • ThinkEquity initiated coverage on PetVivo Holdings with a new price target

      ThinkEquity initiated coverage of PetVivo Holdings with a rating of Buy and set a new price target of $7.00

      10/12/21 11:03:37 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lai John bought $90,000 worth of shares (150,000 units at $0.60), increasing direct ownership by 13% to 1,288,592 units (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/17/24 5:28:07 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Financials

    Live finance-specific insights

    See more
    • PetVivo Reports Fiscal Q3 2025 Results

      MINNEAPOLIS, MN, US, Feb. 14, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), a leading biomedical company delivering innovative therapeutics and medical devices for equines and companion animals, reported results for its fiscal third quarter ended December 31, 2024. All comparisons are to the same year-ago period unless otherwise noted. The company will hold a conference call today at 3:00 p.m. Eastern time to discuss the results for the period (see dial-in information below). Fiscal Q3 2025 Financial Highlights Revenues totaled $583,000, up 191% sequentially and declined 2% from the same year ago period, reflecting the company's continued efforts from targetin

      2/14/25 3:10:00 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2024

      MINNEAPOLIS, MN, US, Feb. 11, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, OTC:PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on Friday, February 14, 2025 after market close. The company will host a conference call to discuss these results at 2:00 p.m. CT (3:00 p.m. ET) on the same day. Attendees of the live webcast of the conference call and related earnings release materials can register and access the webcast on PetVivo's Investor Relations website at: https://audience.mysequire.com/webinar-view?webinar_id=b5c71aaf-5545-4297-93c3-e23bfb001608. A replay of the

      2/11/25 10:15:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PETVIVO HOLDINGS, INC. TO HOST SHAREHOLDERS UPDATE MEETING ON JANUARY 8, 2025

      MINNEAPOLIS, MN, US, Dec. 30, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will host a live webcast Shareholders Update Meeting to provide an overview of the Company's progress in the 2025 fiscal year and a look into the potential future of the Company. The Shareholders Update Meeting: 2025 Company Overview will be held on Wednesday, January 8, 2025 at 3:30 p.m. CT (4:30 p.m. ET). Attendees of the Shareholders Update Meeting live webcast and conference call can register and access the webcast on PetVivo's Investor Relations website at: https://audience.m

      12/30/24 10:23:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    SEC Filings

    See more
    • PetVivo Holdings Inc. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement

      8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

      5/7/25 11:48:49 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form 8-K filed by PetVivo Holdings Inc.

      8-K - PetVivo Holdings, Inc. (0001512922) (Filer)

      4/8/25 3:35:35 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form SCHEDULE 13G filed by PetVivo Holdings Inc.

      SCHEDULE 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

      4/4/25 4:40:47 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Financial Officer Lowenthal Garry N was granted 75,000 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/15/25 4:36:36 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Chief Executive Officer Lai John was granted 100,000 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      4/15/25 4:34:14 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Chief Financial Officer Lowenthal Garry N was granted 160,904 shares (SEC Form 4)

      4 - PetVivo Holdings, Inc. (0001512922) (Issuer)

      1/27/25 6:27:15 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

      SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

      11/19/24 3:38:53 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • SEC Form SC 13G filed by PetVivo Holdings Inc.

      SC 13G - PetVivo Holdings, Inc. (0001512922) (Subject)

      11/4/24 1:57:37 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • Amendment: SEC Form SC 13G/A filed by PetVivo Holdings Inc.

      SC 13G/A - PetVivo Holdings, Inc. (0001512922) (Subject)

      10/1/24 5:26:09 PM ET
      $PETV
      Medical/Dental Instruments
      Health Care

    $PETV
    Leadership Updates

    Live Leadership Updates

    See more
    • PetVivo Engages Former Dechra North American President, Mike Eldred as Commercial and Operations Advisor

      PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW)), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Mike Eldred as the Company's Commercialization and Operations Advisor. His appointment as an Executive Director by the Company's Board of Directors draws upon Mr. Eldred's 30 years of executive experience in animal health and the veterinary industry to ramp up its product development and sales efforts. For the past 20 years, Mr. Eldred served as President of North American Operations for Dech

      1/27/25 9:29:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PetVivo Engages Another Top Sales Manager, Cindy Gill, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

      MINNEAPOLIS, MN, Oct. 21, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW))), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Cindy Gill to the position of field veterinary business development manager for the entire states of Oklahoma and Arkansas and the northern region of Texas. "Cindy's experience and strong record of sales achievement with veterinary clinics brings to our sales team a valuable resource for achieving our business goals," PetVivo CEO, John Lai. "Her experience with other veterinary products and her knowledge of clinic operations enables her to prioritize and better address the veterinarians and cli

      10/21/24 9:45:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care
    • PetVivo Taps Top Sales Executive, Skylor Walker, for Regional Business Development Manager, as Adoption of Breakthrough Animal MedTech Device Continues to Spread Nationwide

      MINNEAPOLIS, MN, Sept. 16, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQB:PETV, PETVW))), a leading provider of biomedical therapeutics for equines and companion animals, has appointed Skylor Walker to the new position of field veterinary business development manager for the entire state of Louisiana and the southern region of Texas. "Skylor's experience and strong record of sales achievement with veterinary clinics brings to our sales team a valuable resource for achieving our business goals," PetVivo CEO, John Lai. "Her experience with other hydrogel injectable products enables us to prioritize and better address the veterinarians and clinics in our sales pipeline."

      9/16/24 8:00:00 AM ET
      $PETV
      Medical/Dental Instruments
      Health Care